The National Pharmaceutical Pricing Authority (NPPA) on Wednesday fixed the retail price of 20 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013.
The move aims to address the financial viability of manufacturing these drugs without compromising the mandate to provide affordable medication. NPPA's primary objective is to ensure that essential medicines are available at reasonable prices.
The government has taken action against companies, found selling formulations at prices higher than the permissible price. In the year 2023-24, it has recovered Rs 72.73 crore from the defaulting companies who have overcharged the consumers. Union Minister of State for Chemicals and Fertiliz